VisionWave Holdings, Inc. (VWAV)

Chimerix Balance Sheet

Financials in millions USD. Fiscal year is April - March.

Fiscal Year	FY 2025
Period Ending	Mar 31, 2025
Cash & Equivalents	0.06
Cash & Short-Term Investments	0.06
Other Receivables	0
Receivables	0
Other Current Assets	0.1
Total Current Assets	0.16
Other Long-Term Assets	0.01
Total Assets	0.17
Accounts Payable	0.11
Current Unearned Revenue	0.11
Other Current Liabilities	0.26
Total Current Liabilities	0.47
Total Liabilities	0.47
Additional Paid-In Capital	0.26
Retained Earnings	-0.56
Shareholders' Equity	-0.3
Total Liabilities & Equity	0.17
Net Cash (Debt)	0.06
Working Capital	-0.31
Tangible Book Value	-0.3

Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q